Once a Tiny Fraction of US Approvals, Cancer Drugs Now Dominate Once a Tiny Fraction of US Approvals, Cancer Drugs Now Dominate

In the 1980s, cancer drugs accounted for the smallest share of US approvals among the four major therapeutic classes. In the last decade, they had the largest share — by far.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Hematology-Oncology News Source Type: news